ロード中...

Radiosensitizers in the temozolomide era for newly diagnosed glioblastoma

Glioblastoma (GBM) is a challenging diagnosis with almost universally poor prognosis. Though the survival advantage of postoperative radiation (RT) is well established, around 90% of patients will fail in the RT field. The high likelihood of local failure suggests the efficacy of RT needs to be impr...

詳細記述

保存先:
書誌詳細
出版年:Neurooncol Pract
主要な著者: Mathen, Peter, Rowe, Lindsay, Mackey, Megan, Smart, DeeDee, Tofilon, Philip, Camphausen, Kevin
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7274183/
https://ncbi.nlm.nih.gov/pubmed/32537176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nop/npz057
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!